跳至主要内容
临床试验/NCT06791603
NCT06791603招募中不适用

The Impact of Social Media-delivered Chemotherapy-related Side Effects Education for Breast Cancer Patients Receiving First Time Chemotherapy

Taipei Medical University Shuang Ho Hospital1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年1月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100
试验地点
1
主要终点
A questionnaire with 5 questions of side effects management

研究概览

简要总结

The goal of this clinical trial is to learn if a standardized pharmacists-provided education module by social media can improve patients' knowledge of chemotherapy-related side effects. The main questions it aims to answer is:

• Do patients who received a standardized pharmacists-provided education module by social media improve their knowledge of chemotherapy-related side effects? Researchers will compare standardized chemotherapy education +video (experimental group) versus chemotherapy handouts (control group).

Participants will:

  • Received standardized chemotherapy education + video or chemotherapy handouts at the first and second chemotherapy section.
  • Fill out a questionnaire for outcomes assessment.

详细描述

The pharmacist-provided video education model for patients undergoing first time chemotherapy was developed. The content of the education video included the mechanism of side effects, its recognition, preventive measures, non-medical management, and further instructions when to visit hospital were included.

Patients were randomly assigned into two groups with different education strategies:

Standardized chemotherapy education +video (experimental group) versus chemotherapy handouts (control group). Every patient was asked to fill out a questionnaire prior to the implementation of the education model in both groups. The pre-test questionnaires consisted of baseline knowledge and personal information. Patients in the experimental group would receive standardized chemotherapy education by pharmacists, including chemotherapy regimen, the purpose of chemotherapy, the number of cycles, duration of chemotherapy and the common side effects of chemotherapy on the first day of chemotherapy cycle. Videos will be provided with patients and they will watch videos during the visit. The information regarding the prevention and management of side effects and further instructions when to visit hospital. Patients will have access to videos and watch videos after leaving the hospital for the entire treatment course. The education time will be last around 15 to 20 minutes. In terms of control group, pharmacists will briefly explain and provide chemotherapy handouts, including chemotherapy regimen, the purpose of chemotherapy, the number of cycles, duration of chemotherapy and the common side effects of chemotherapy. The duration of visit will be around 5 to 10 minutes. After the education section, patients will be asked to do a post-test questionnaire of their knowledge and quality of life.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Breast cancer patients aged 18 or older undergoing their first chemotherapy.
  • •Possess a smartphone and are able to watch videos on it.

排除标准

  • •Unable to read or complete questionnaires in Chinese.
  • •Cognitive impairments.
  • •Pregnant women.

研究组 & 干预措施

Standardized chemotherapy education + video

Experimental

Standardized chemotherapy education+ video

干预措施: Standardized chemotherapy education + video (Other)

Chemotherapy handouts

No Intervention

Chemotherapy handouts

结局指标

主要结局

A questionnaire with 5 questions of side effects management

时间窗: 1. First time receiving chemotherapy 2. Second time receiving chemotherapy (3 to 4 weeks depend on schedule)

Each question is a multiple choice with 4 options and 1 correct answer

次要结局

  • FACT-B, The Functional Assessment of Cancer Therapy - Breast(1. First time receiving chemotherapy 2. Second time receiving chemotherapy (3 to 4 weeks depend on schedule))

研究者

发起方
Taipei Medical University Shuang Ho Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Pohung Lin

Principal Investigator, clinical pharmacist

Taipei Medical University Shuang Ho Hospital

研究点 (1)

Loading locations...

相似试验